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BACKGROUND:  Damp  conditions  indoors  favour  the
growth of microorganisms, and these contain several
agents that may cause inflammation when inhaled.
Moulds  contain  a  polyglucose  in  their  cell  wall,
defined  as  (1® 3)-b -D-glucan,  exhibiting  effects  on
inflammatory cells.
Aim: The aim  of the present study  was to  evaluate
whether  an  inhalation  challenge  to  purified
(1® 3)-b -D-glucan (grifolan) in humans could induce
effects  on  inflammatory  markers  in  blood,  and  to
evaluate whether the reactions  were related  to  the
home exposure to (1® 3)-b -D-glucan.
Methods:  Seventeen  subjects  in  homes  with  high
levels of airborne (1® 3)-b -D-glucan (G-high) and 18
subjects in homes with low levels of (1® 3)-b -D-glucan
(G-low)  underwent  two  randomised,  double-blind
inhalation challenges, one to  (1® 3)-b -D-glucan sus-
pended in saline and  one  to  saline  alone. A blood
sample was taken before and after the challenges, and
differential cell count, granulocyte enzymes in serum
and the secretion of cytokines from peripheral blood
mononuclear cells (PBMC) were measured.
Results: Inhalation challenge with (1® 3)-b -D-glucan
induced a decrease in the secretion of tumour necro-
sis factor  a from endotoxin-stimulated PBMC in the
G-high group as well as in the G-low group. In the
G-high  group,  the  inhalation  of  (1® 3)-b -D-glucan
induced an increase in blood lymphocytes that was
significantly  different  from  the  saline-induced
effect.
Conclusions: The results suggest that an inhalation
challenge  to  (1® 3)-b -D-glucan  has  an  effect  on
inflammatory cells and this effect may be related to a
chronic exposure to moulds at home.
Key  words:  Moulds,  (1® 3)-b-D-Glucan,  Inflammation,
Cytokines, Lymphocytes
Introduction
A large number of investigations has reported a higher
prevalence  of  respiratory  symptoms  and  asthma
among children and adults living in damp houses.1–7
Damp  conditions  indoors  favour  the  growth  of
microorganisms, and these contain several agents that
may cause inflammation when inhaled. The relation
between  bacterial  endotoxin  from  Gram-negative
bacteria and airways inflammation has been descri-
bed in several studies.8–10 Exposure to high concen-
trations  of  moulds  may  cause  inflammation  in  the
airways characterised by an involvement of lympho-
cytes. Prolonged exposure may lead to a granuloma-
tous pneumonitis (i.e. allergic alveolitis).11,12
Moulds  contain  a  polyglucose  in  their  cell  wall,
defined  as  (1® 3)-b-D-glucan.  Results  from  in  vitro
and  animal  exposure  studies  demonstrate  that  this
agent can affect the function of the defence system
in the lungs by changing the reaction to an inhaled
inflammagenic agent, endotoxin, as well  as to anti-
gens.13 A previous study demonstrated that persons
living in houses with fungal contamination, as meas-
ured  by  the  amount  of  airborne  (1® 3)-b-D-glucan,
had  a  higher  spontaneous  secretion  of  tumour
necrosis  factor  a (TNFa)  from  peripheral  blood
mononuclear  cells  (PBMC),  and  a  reduced  propor-
tion  of  CD8+ T  cells  in  blood,  as  compared  with
subjects  living  in  homes  with  low  levels  of
(1® 3)-b-D-glucan.14
The  aim  of  the  present  study  was  to  evaluate
weather  an  experimental  exposure  to  purified
(1® 3)-b-D-glucan could induce symptoms and effects
on inflammatory markers in blood, and whether the
reactions  were  related  to  the  home  exposure  of
(1® 3)-b-D-glucan.
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Subjects
Subjects for the study were recruited from a previous
investigation in a rowhouse area15 and by advertising
in  the  local  press,  requesting  persons  suspecting
mould growth in their homes. Inclusion criteria were
age 19–65 years, non-smokers and without physician-
diagnosed asthma or diseases requiring  medication.
The  amount  of  airborne  (1® 3)-b-D-glucan  in  the
subject’s homes were measured and two groups were
selected: those with lower than  2.0ng/m3 (G-low),
and those with higher than 4.0ng/m3(G-high) in their
homes. One subject was recruited from each home,
except for three homes in the G-low group and two
homes  in  the  G-high  group,  where  couples  were
recruited. The  study  was  approved  by  the  Ethics
Committee of the Faculty  of  Medicine at G¨ oteborg
University,  and  all  participating  subjects  gave  their
informed consent. Table 1 presents the home levels of
(1® 3)-b-D-glucan, the number of subjects and their
characteristics.
Determination of (1® 3)-b-D-glucan
To determine the exposure in the subjects’ homes,
airborne dust was created using a machine designed
to whirl up dust roughly equivalent to that generated
by a few people moving about the room.15The dust
generator  was  run  for  5min  followed  by  a  10-min
pause. Two such periods were used for the sampling.
Air  samples  were  taken  during  these  30min  by
drawing air at a flow rate of 5l/min through parallel
filters (Isopore, ATTP 0.8mm; Millipore Inc., Bedford,
MA, USA), placed 0.8m above the floor. Two rooms,
usually  the  bedroom  and  the  living  room,  were
investigated in each home.
The  filters  were  shaken  for  10min  in  10ml  of
pyrogen-free  water.  Thereafter,  0.3M  NaOH  was
added and the filters were shaken on ice for 10min to
unwind  the  triple  helix  structure  of  the
(1® 3)-b-D-glucan  and  make  it  water  soluble.  Filter
extract samples of 50ml were placed in a microwell
plate  and  50ml  of  specific  (1® 3)-b-D-glucan  lysate
(Fungitic G Test®; Seikagaku Co, Tokyo, Japan) was
added.  The  plate  was  incubated  in  a  microplate
spectrophotometer, and the kinetics of the ensuing
colour  reaction  was  read  and  compared  with  a
standard curve (Pachyman, T; Seikagaku Co., Tokyo,
Japan). The results were expressed as nanograms per
millilitre  of  liquid  and  the  detection  limit  for  this
technique is 20pg/ml. The airborne concentration of
(1® 3)-b-D-glucan was calculated using the value for
the airflow through the filter, and the mean exposure
value in a house was based on four filters.
Inhalation challenge
Grifolan, a (1® 3)-b-D-glucan extracted from Grifola
frondosa, was suspended in 0.3M NaOH to dissolve
the  triple  helix  and to render the substance  water
soluble.  The  solution  was  diluted  840  times  with
pyrogen-free  saline  to  a  final  concentration  of
6mg/ml. The inhalation challenge was performed in a
chamber, 2m ´ 3.5m ´ 2.45m, furnished as a sitting
room. The solution was aerosolised and led into the
chamber through the ventilation system. Each subject
inhaled (1® 3)-b-D-glucan in saline or saline alone on
two  double-blind,  randomised  occasions.  One  to
three  subjects  were  challenged  at  the  same  time.
Three Isopore filters were placed in the chamber and
the amount of airborne (1® 3)-b-D-glucan was deter-
mined. The inhalation challenge time was 3h and the
mean  concentrations  during  the  (1® 3)-b-D-glucan
inhalations were 28.1ng/m3(range, 17.1–44.9ng/m3)
for  the  G-low  group  and  mean  27.0ng/m3 (range,
15.3–44.9ng/m3) for the G-high group.
Exposure endpoints
Blood  samples  were  taken  from  each  subject  for
analyses of serum inflammatory markers and cytokine
secretion from PBMC. The samples were taken before,
immediately  after and 24h after  the inhalation. No
differences were found in  any variable immediately
after  the  inhalations  of  (1® 3)-b-D-glucan  or  saline
L. Beijer et al.
150 Mediators of Inflammation · Vol 11 · 2002
Table 1. Population characteristics and levels of (1® 3)-b-D-glucan (GLU) in the home (ng/m
3)
G-low group G-high group
Subjects n 18 17
Home GLU levels Median 0.9 6.0
Range 0.2–1.9 4.1–51.7
Female n 9 6
% 50 35
Atopics n 6 5
% 33 29
Age (years) Median 52 45
Range 26–66 19–59
G-high group, ‡  4ng/m3 GLU in their homes; G-low group, < 2ng/m3 GLU in their homes.alone as compared with pre-inhalation values; thus,
only before and 24h results are reported
Inflammatory markers
Venous  blood  was  collected  in  ethylenediamine
tetraacetic acid tubes, and a differential cell count was
made on smears stained with May–Gr¨ unwald–Giemsa
and  counted  in  a  light  microscope.  Eosinophilic
cationic  protein  (ECP)  was  assayed  in  serum  by  a
fluorescent  enzyme  immunoassay  technique  (CAP
ECP FEIA; Pharmacia Diagnostics AB, Uppsala, Swe-
den).  Myeloperoxidase  (MPO)  was  assayed  by  a
radioimmunoassay technique (CAP MPO RIA; Pharma-
cia Diagnostics AB).
Cytokine production
Venous  blood  was  collected  in  vacutainer  tubes
containing sodium citrate, a gel barrier and a density
gradient fluid (CPT™ tubes; Becton Dickinson, Frank-
lin  Lakes, NJ, USA). After centrifugation, the PBMC
were collected and washed twice in Hank’s salt buffer
supplemented  with  10%  homologues  serum.  The
PBMC were then suspended in AIM-V medium (Gibco
BRL,  Life  Technologies,  UK)  supplemented  with
2-mercaptoethanol, 4 ´ 10–5M to a concentration of 2
´ 106/ml. The cells were incubated with or without
phytohaemagglutinin (PHA) (Murex Diagnostics Lim-
ited, Dartford, UK) at a final concentration of 250ng/
ml,  or  lipopolysaccharide  (LPS)  (Escherichia  coli
026:B6; Difco Laboratories, Detroit, MI, USA) at a final
concentration of 500pg/ml. PHA was used as a major
T-cell stimulus and LPS as a major monocyte stimulus.
After  48h  incubation  at  37°C/5%  CO2,  the  super-
natants were collected and  stored at  –25°C  before
cytokine analysis. TNFa from unstimulated PBMC was
analysed  using  an  enzyme-linked  immunosorbent
assay  (ELISA)  kit  with  a  sensitivity  of  0.1pg/ml
(Quantikine high sensitive; R&D Systems, Abingdon,
UK). Interleukin (IL)-1b, IL-4, IL-10, interferon g and
TNFa from stimulated PBMC were analysed using the
PeliKine-compact™  human  cytokine  ELISA  (CLB,
Amsterdam, The Netherlands).
Atopy
Atopy was determined by measuring the concentra-
tion of specific serum immunoglobulin E antibodies
against  a  pool  of  10  airborne  allergens  using  a
fluorescent  enzyme  immunoassay  technique  (CAP
Phadiatop  FEIA;  Pharmacia  Diagnostics  AB).  The
results were expressed as positive (atopic) or negative
(non-atopic). Due to the low number of subjects, no
separate analyses of  atopic and non-atopic subjects
could be carried out.
Statistical analyses
The differences in effect variables comparing before
values  with  immediately  after  and  24h  after  the
inhalation  challenge,  as  well  as  the  differences
between the (1® 3)-b-D-glucan and saline challenges
within the G-high and the G-low groups were analysed
using Wilcoxon’s test. The differences in effects after
challenge between the G-high and G-low groups were
analysed using the Mann–Whitney U-test. Differences
were considered statistically significant at p < 0.05.
Results
Table  2  presents  the  secretion  of TNFa from  LPS-
stimulated PBMC before and 24h after inhalation of
saline  and  (1® 3)-b-D-glucan  in  relation  to  the
(1® 3)-b-D-glucan  exposure  in  the  subjects’  homes.
Among  G-low  subjects,  the  inhalation  of  saline  or
(1® 3)-b-D-glucan did not influence the LPS-induced
secretion  of  TNFa from  PBMC.  Among  G-high
subjects,  the  TNFa secretion  was  not  influenced
by  inhalation  of  saline.  After  inhalation  of
(1® 3)-b-D-glucan, the LPS-induced secretion of TNFa
was lower than before (p < 0.02). The change (before
–24h after inhalation) induced by (1® 3)-b-D-glucan
was statistically significant compared with the change
after saline (p < 0.01). The change in TNFa secretion
after  inhalation  of  (1® 3)-b-D-glucan  was  also  sig-
nificantly different when comparing the G-high group
with the G-low group (p < 0.02).
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Table 2. TNFa (pg/ml) secreted from PBMC stimulated with LPS in vitro before and 24h after saline and (1® 3)-b-D-glucan (GLU)
inhalations
G-low group G-high group
Saline inhalation GLU inhalation Saline inhalation GLU inhalation
n 18 18 14 14
Before challenge 122 (8–419) 98 (6–393) 71 (13–232) 107 (25–724)
24h after challange 137 (47–403) 101 (6–422) 76 (21–460) 61 (1–531)*
Challenge-induced change 9.3 (–224 to 132) 3.8 (–125 to 271) 11.5 (–55 to 305) –46.7 (–595 to 53)†‡
Data presented as medians (ranges). G-high group, ‡  4ng/m3 GLU in their homes; G-low group, < 2ng/m3 GLU in their homes.
* p < 0.05 comparing after challenge with before challenge.
† p < 0.01 comparing inhalation of GLU with inhalation of saline.
‡ p < 0.05 comparing the G-high group with the G-low group after GLU inhalation.There  was  a  significant  negative  correlation
between the amount of (1® 3)-b-D-glucan in the air in
the  exposure  chamber  and  the  LPS-induced TNFa
secretion from PBMC after the challenge (rxy = –0.40,
p < 0.05). This correlation was present in the G-low
group but not in the G-high group.
Table 3 presents the secretion of IL-10 from PBMC
stimulated with LPS before and 24h after the inhala-
tion of saline and (1® 3)-b-D-glucan in relation to the
(1® 3)-b-D-glucan  exposure  in  the  subjects’  homes.
The  difference  before  –24h  after  inhalation  of
(1® 3)-b-D-glucan was significantly different from that
induced by saline (p < 0.05).
Table  4  presents  the  number  of  lymphocytes  in
blood  before  and  24h  after  the  inhalation  of
(1® 3)-b-D-glucan  and  saline  in  relation  to  the
(1® 3)-b-D-glucan  exposure  in  the  subjects’  homes.
Among  G-low  subjects,  the  inhalation  of  saline  or
(1® 3)-b-D-glucan did not induce any significant chan-
ges 24h after inhalations. Among G-high subjects, the
increase induced by the (1® 3)-b-D-glucan inhalation
was significant as compared with the change induced
by the saline inhalation (p < 0.02). The change after
inhalation of  (1® 3)-b-D-glucan  in  the G-high  group
was  on  the  borderline  of  statistical  significance  as
compared with the change in the G-low group (p =
0.05).
No  significant  differences  were  found  24h  after
inhalation of (1® 3)-b-D-glucan or saline regarding the
PBMC secretion of IL-1b, IL-4, interferon g or ECP and
MPO in serum.
Discussion
The design of this study, selecting groups with ‘high’
and ‘low’  (1® 3)-b-D-lucan  exposure  at  home,  was
chosen because no information on (1® 3)-b-D-glucan-
induced  dose–response  relationships  or
(1® 3)-b-D-glucan  levels  for  triggering  inflammatory
reactions were available at the start of the study. Using
well-discriminated groups, according to the exposure
variable, would therefore increase the possibility of
demonstrating differences related to the exposure.
A larger number of dwellings was measured, after
which the two groups were selected. The limits used
for high and low exposure were based on the results
from  the  previous  study,  in  which  30%  of  the  75
houses examined had a (1® 3)-b-D-glucan level above
4ng/m3 and 30% of the houses had a glucan level less
than 2.0ng/m3.15
The  subjects  recruited  to  the  study  represent  a
biased  population  sample,  as  they  were  aware  of
problems  related to  mould  exposure  at  home. The
assignment into exposure groups was, however, made
according  to  measurements  of  (1® 3)-b-D-glucan  in
the home, irrespectively of the presence of indoor-
related symptoms.  It  is thus  unlikely  that selection
bias according to symptoms accounted for the differ-
ences  found  in  the  variables  measured  in  blood
between the G-low and G-high groups.
The main result from the study is that the inhalation
challenge with (1® 3)-b-D-glucan decreased the capac-
ity  of PBMC to secrete TNFa after  an  in vitro LPS
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Table 3. IL-10 (pg/ml) secreted from PBMC stimulated with LPS in vitro before and 24h after saline and (1® 3)-b-D-glucan (GLU)
inhalations
G-low group G-high group
Saline inhalation GLU inhalation Saline inhalation GLU inhalation
n 18 18 14 14
Before exposure 140 (4–462) 146 (2–910) 129 (14–907) 90 (14–973)
24h after exposure 131 (13–639) 138 (19–623) 78 (9–963) 69 (1–762)
Exposure-induced change 1.7 (–92 to 377) –13.7 (–287 to 169) –10.2 (–123 to 323) –10.5 (–211 to 107)*
Data presented as medians (ranges). G-high group, ‡  4ng/m3 GLU in their homes; G-low group, < 2ng/m3 GLU in their homes.
*p < 0.05 comparing inhalation of GLU with saline.
Table 4. The numbers of lymphocytes (´ 10
9/l) in blood before and 24h after saline and (1® 3)-b-D-glucan (GLU) inhalations
G-low group G-high group
Saline inhalation GLU inhalation Saline inhalation GLU inhalation
n 18 18 17 17
Before challenge 2.2 (1.2–3.6) 2.6 (0.8–4.6) 2.1 (1.2–4.0) 1.9 (1.2–3.9)
24h after challenge 2.4 (1.1–4.0) 2.1 (1.2–3.3) 1.8 (1.2–4.5) 2.1 (1.2–4.6)
Challange induced change 0.3 (–0.9 to 1.0) –0.2 (–2.2 to 0.7) –0.3 (–1.4 to 0.9) 0.1 (–0.3 to 0.9)*†
Data presented as medians (ranges). G-high group, ‡  4ng/m3 GLU in their homes; G-low group, < 2ng/m3 GLU in their homes.
* p < 0.05 comparing inhalation of GLU with saline.
† p = 0.05 comparing the G-high group with the G-low group after GLU inhalation.stimulation.  This  effect  was  found  in  the  group
previously  exposed  to  a  higher  level  of
(1® 3)-b-D-glucan in their homes, indicating an effect
of  chronic  exposure.  In  the  G-low  group,  the
(1® 3)-b-D-glucan challenge did not induce a reduced
TNFa secretion  measured  as  a  group  value,  but  a
negative correlation was found between the amount
of  (1® 3)-b-D-glucan  in  the inhalation chamber  and
the LPS-induced TNFa secretion from PBMC after the
challenge. This (1® 3)-b-D-glucan-induced effect was
confirmed in a recent study, where a decreased TNFa
secretion  from  PBMC  was  found  in  volunteers,
without  indoor  air  problems  at  home,  after  an
inhalation  challenge  with  (1® 3)-b-D-glucan  via  a
nebuliser.16
These findings are supported by data from animal
models where a down-regulation of the inflammatory
response  after  pretreatment  with  (1® 3)-b-D-glucan
has  been  shown.  In  mice  given  (1® 3)-b-D-glucan
intramuscularly,  a  decreased TNFa secretion  from
mononuclear cells after an in vivo stimulation with
LPS  was  demonstrated.17 Repeated  inhalations  of
(1® 3)-b-D-glucan prior to an inhalation challenge to
LPS  decreased the  LPS-induced  neutrophil  invasion
into the airways of guinea pigs.18
The  effects  in  blood  lymphocytes  did  not  differ
significantly  in  the  G-low  group  after  the  saline  or
(1® 3)-b-D-glucan challenges, but in the G-high group
the (1® 3)-b-D-glucan challenge induced an increase
in lymphocytes that was significantly  different from
the  saline  challenge  effect.  Previous  studies  have
shown relations between mould exposure and effects
on blood lymphocytes. Household waste collectors,
exposed to levels of (1® 3)-b-D-glucan similar to the
levels used in the exposure chamber in this study, had
an increased number of blood lymphocytes compared
with control subjects, and the lymphocyte numbers
were  correlated  to  the  exposure  levels  of
(1® 3)-b-D-glucan.19 Dales et al. found that children
living  in  more  fungal-contaminated  homes  did  not
differ in blood lymphocyte numbers compared with
children living in less fungal-contaminated homes, but
certain subtypes of T cells were significantly increased
among  the  more  fungal-exposed  children.20 These
data suggest that exposure to moulds influences the
lymphocyte  homeostasis, akin to what is known in
allergic alveolitis.
In  summary,  the  present  results  suggest  that  an
inhalation challenge to (1® 3)-b-D-glucan has an effect
on inflammatory cells,  shown as both increased as
well  as  decreased effects  in  inflammatory  markers.
Persons  living  in  houses  with  levels  of
(1® 3)-b-D-glucan above 4ng/m3 (indicator of mould
growth)  show  an  increased  reactivity  to  an  acute
inhalation challenge to (1® 3)-b-D-glucan.
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